Travere Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

SAN DIEGO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics (NASDAQ: TVTX) announced that Eric Dube, Ph.D., CEO, will present a corporate overview at the 41^st Annual J.P. Morgan Healthcare Conference on January 12, 2023, at 11:15 a.m. PT. A live webcast will be available on the company's website, with an archived replay accessible for 30 days.

Travere Therapeutics focuses on developing therapies for rare diseases, collaborating with the community to understand patient needs and deliver impactful treatments.

SAN DIEGO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present a corporate overview at the 41^st Annual J.P. Morgan Healthcare Conference, on Thursday, January 12, 2023, at 11:15 a.m. PT.

A live webcast of the presentation will be accessible on the company’s website, ir.travere.com, under the “Events & Presentations” section, and an archived replay will be accessible for up to 30 days.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.

Contact:
Naomi Eichenbaum 
Vice President, Investor Relations
IR@travere.com
888-969-7879

FAQ

When is Travere Therapeutics presenting at the J.P. Morgan Healthcare Conference?

Travere Therapeutics will present on January 12, 2023, at 11:15 a.m. PT.

Who will present for Travere Therapeutics at the conference?

Eric Dube, Ph.D., the CEO of Travere Therapeutics, will present.

How can I watch the Travere Therapeutics presentation?

The presentation will be available via live webcast on the Travere Therapeutics website.

Will the Travere Therapeutics presentation be recorded?

Yes, an archived replay of the presentation will be available for 30 days.

What is the focus of Travere Therapeutics?

Travere Therapeutics is dedicated to developing therapies for rare diseases.